A biotechnology company, Nutra Pharma Corporation (OTCQB: NPHC) focuses on acquiring, licensing, and commercializing pharmaceutical products and technologies. The company concentrates on preventing and treating neurological disorders, cancer, and autoimmune and infectious diseases. Currently, Nutra Pharma offers Nyloxin® and Nyloxin® Extra Strength, the only non-narcotic and non-addictive treatments for severe pain that are sold over-the-counter. […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.